Androgen-responsive FOXP4 is a target for endometrial carcinoma.
Kayahashi K, Hasan M, Khatun A, Kohno S, Terakawa J, Horike SI, Toyoda N, Matsuoka A, Iizuka T, Obata T, Ono M, Mizumoto Y, Takahashi C, Fujiwara H, Daikoku T.
Kayahashi K, et al. Among authors: toyoda n.
Commun Biol. 2024 Jun 18;7(1):740. doi: 10.1038/s42003-024-06433-w.
Commun Biol. 2024.
PMID: 38890503
Free PMC article.